Haleon Pakistan Limited (PSX:HALEON)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
788.19
-1.14 (-0.14%)
At close: Mar 27, 2025

Haleon Pakistan Company Description

Haleon Pakistan Limited engages in the manufacture, marketing, and sale of consumer healthcare products in Pakistan, Africa, Australia, North America, Asia, the Middle East, and Europe.

The company offers oral health, pain relief, vitamins and mineral supplements, and respiratory health products.

It sells its products under the Panadol, CaC-1000 Plus, Sensodyne, paradontax, T-Day, ENO, Hydrozole, Qalsium-D, and Voltral Emulgel brands.

The company also exports its products to the Philippines, Vietnam, and East West Africa region. The company was formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited and changed its name to Haleon Pakistan Limited in January 2023.

Haleon Pakistan Limited was incorporated in 2015 and is headquartered in Karachi, Pakistan. Haleon Pakistan Limited is a subsidiary of Glaxosmithkline Consumer Healthcare B.V.

Haleon Pakistan Limited
Country Pakistan
Founded 2015
Industry Pharmaceutical Preparations
Employees 450
CEO Farhan Haroon

Contact Details

Address:
11-A, Sky Tower (East Wing)
Karachi, 75600
Pakistan
Phone 92 21 111 425 366
Website haleon.pk

Stock Details

Ticker Symbol HALEON
Exchange Pakistan Stock Exchange
Fiscal Year January - December
Reporting Currency PKR
SIC Code 2834

Key Executives

Name Position
Farhan Haroon Chief Executive Officer
Dilawar Meghani Chief Financial Officer